FDA Issues Warning On Dangers Of Mixing Opioid Addiction Medications, Other Treatments

The AP (9/20, Johnson) reports the FDA on Wednesday issued a new set of warnings on the dangers of combining prescription treatments for opioid addiction with anti-anxiety medicines and other medications. According to the FDA, mixing the drugs leads to slowed or difficulties with breathing and impaired cognitive function. FDA Commissioner Scott Gottlieb wrote in a statement accompanying the warning, “Careful management of the patient and coordination of care is recommended” over denying opioid addicts the use of treatment with methadone or buprenorphine.

Related Links:

— “FDA WARNS ON MIXING OPIOID ADDICTION TREATMENTS, OTHER MEDS,” LINDA A. JOHNSON, AP, September 20, 2017.

Posted in In The News.